Ewa Małecka‐Panas

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou et al. · Gastroenterology · 2016 · 320 citations · Full text

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 277 citations

Immunology, Clinical Trials, Gastroenterology +7

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer

Erica J. Childs, Evelina Mocci, Daniele Campa et al. · Nature Genetics · 2015 · 265 citations · Full text

Pancreatic Cancer, Medicine, Pathology +8

Pancrelipase Delayed-Release Capsules (CREON) for Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-Blind Randomized Trial

David C. Whitcomb, Glen A. Lehman, G. A. VASIL'EVA et al. · The American Journal of Gastroenterology · 2010 · 188 citations

Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients

Anna Kumor, Piotr Daniel, Mirosława Pietruczuk et al. · International Journal of Colorectal Disease · 2008 · 137 citations

Obesity, Metabolic Syndrome, Resistin Concentration +7